Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial

Abstract

A selective policy for the management of the axilla is associated with no increase in axillary recurrence or mortality rate compared with routine axillary node clearance. Patients who are node negative after axillary sample can avoid radiotherapy or axillary clearance.